Musk calls mRNA technology a 'software problem' after successful cancer vaccine trials
Elon Musk shared his thoughts following the role of AI in assisting US companies Moderna and Merck with the creation of a personalized mRNA cancer vaccine. He noted that while mRNA was clearly misused throughout the COVID pandemic, the technology holds immense potential for treating illnesses. Musk remarked that artificial RNA effectively turns the process of curing diseases into a software challenge. In recent clinical trials, the vaccine proved effective at preventing melanoma from spreading or recurring in patients who had previously undergone surgery to remove tumors.
by shortkt.com✓